Dann EJ. Response to Comment on: “Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?”. haematol [Internet]. 2020Sep.10 [cited 2026May30];. Available from: https://haematologica.org/article/view/14215